See also this year's filing and all EDGAR filings for this company.
PDF Report 0001621221_2025_Artelo_Biosciences_INC.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001621221, Artelo Biosciences INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 2,557,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 2,039,000 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 102,000 |
| 4 | LiabilitiesCurrent | 1,772,000 |
| 5 | LiabilitiesNoncurrent | 69,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 4,027,479 |
| 9 | ResearchAndDevelopmentExpense | 6,031,066 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 271,266 |
| 13 | remainder_ComprehensiveNetIncome | 16,185 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 4,698,000 |
| 1 | Liabilities | 1,841,000 |
| 2 | Expenses | 10,058,545 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 2,857,000 |
| 5 | NetIncome | -9,787,279 |
| 6 | ComprehensiveNetIncome | -9,779,186 |
| 7 | BaseVar | 8,442,498 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -1.09 |
| 9 | EconomicCapitalRatio | 1.28 |
Edgar->Model Mapping
Feature Distribution
Change over Time
